2m 2m 2m 2m 2m 2m 2m
BAUSCH HEALTH (BHC)
NYSE
$5.94+$0.08 (+1.43%)
Price as of Sep 11, 2026 7:47 PM EDT- $2.2BMarket Cap
- -19.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BAUSCH HEALTH (BHC)
$5.94+$0.08 (+1.43%)
BHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.86 | ||
Change | -$0.21 (-3.46%) | ||
Open | $6.12 | ||
High | $6.13 | ||
Low | $5.83 | ||
Previous Close | $6.07 | ||
Volume | 2,406,541 | ||
30-Day Average Volume | 2,653,550 | ||
1-Week Change | -10.67% | ||
1-Month Change | -6.09% | ||
1-Year Change | -19.28% | ||
3-Year Change | -32.49% | ||
5-Year Change | -79.40% | ||
Fundamentals | |||
Shares Outstanding | 374.1M | ||
Total Assets | $24.8B | ||
Market Cap | $2.2B | ||
Enterprise Value | $21.1B | ||
Period: QTR TTM FY | |||
Revenue | $2.8B | ||
Net Income | $258.0M | ||
Free Cash Flow | $593.0M | ||
EBIT | $742.0M | ||
EBITDA | $1.0B | ||
Net Working Capital | $2.0B | ||
EPS | $0.68 | ||
Enterprise Value/EBITDA | 21 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -1 | ||
P/E | 9 | ||
PEG | 0 | ||
Price/Free Cash Flow | 4 | ||
Price/Operating Cash Flow | 3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/10/2010 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue